Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Operating Income

Profit from core operations after operating expenses, before interest and taxes.

No reported Operating Income figures are available to summarize.

Operating Income history

Currency unavailable · from the income statement

No Operating Income data reported for this period type.

Operating Income vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Operating Income for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MNKDMannKind CorporationLTM Mar 2026$13.4M USD-82.9%—3.7%
GYREGyre Therapeutics, Inc.LTM Mar 2026-$139K USD-101.3%+7.7%0.1%
VCREVicore Pharma Holding ABLTM Jun 2026-SEK 285.35M SEK+26.7%—21455.4%
INSMInsmed IncorporatedLTM Jun 2026-$817.54M USD+18.6%—71.9%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-32.1%+7.7%37.8%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.